Depreciation of TScan Therapeutics, Inc. from 31 Dec 2020 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
TScan Therapeutics, Inc. annual and quarterly Depreciation in USD history and change rate from 31 Dec 2020 to 31 Dec 2025.
  • TScan Therapeutics, Inc. Depreciation for the quarter ending 31 Mar 2025 was $678,000, a 46% decline year-over-year.
  • TScan Therapeutics, Inc. annual Depreciation for 2025 was $2,866,000, a 30% decline from 2024.
  • TScan Therapeutics, Inc. annual Depreciation for 2024 was $4,108,000, a 23% decline from 2023.
  • TScan Therapeutics, Inc. annual Depreciation for 2023 was $5,361,000, a 4.4% increase from 2022.
Source SEC data
View on sec.gov
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)

TScan Therapeutics, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $2,866,000 -$1,242,000 -30% 01 Jan 2025 31 Dec 2025 10-K 04 Mar 2026 2025 FY
2024 $4,108,000 -$1,253,000 -23% 01 Jan 2024 31 Dec 2024 10-K 04 Mar 2026 2025 FY
2023 $5,361,000 +$224,000 +4.4% 01 Jan 2023 31 Dec 2023 10-K 05 Mar 2025 2024 FY
2022 $5,137,000 +$1,809,000 +54% 01 Jan 2022 31 Dec 2022 10-K 06 Mar 2024 2023 FY
2021 $3,328,000 +$2,098,000 +171% 01 Jan 2021 31 Dec 2021 10-K 08 Mar 2023 2022 FY
2020 $1,230,000 01 Jan 2020 31 Dec 2020 10-K 09 Mar 2022 2021 FY

TScan Therapeutics, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $678,000 -$576,000 -46% 01 Jan 2025 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q1 2024 $1,254,000 -$245,000 -16% 01 Jan 2024 31 Mar 2024 10-Q 06 May 2025 2025 Q1
Q1 2023 $1,499,000 +$304,000 +25% 01 Jan 2023 31 Mar 2023 10-Q 13 May 2024 2024 Q1
Q1 2022 $1,195,000 +$726,000 +155% 01 Jan 2022 31 Mar 2022 10-Q 10 May 2023 2023 Q1
Q1 2021 $469,000 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.